NOCTI Guide
4 in 10 Who Wanted the PrEP Shot Never Got It. Insurance Did That
At one big St. Louis clinic, about 4 in 10 people prescribed the long-acting PrEP shot never got a single injection. The reason wasn't fear. It was paperwork. Here's what happened and how to protect yourself.
The prescription was written. The shot never happened.
Picture this: you finally have the grown-up talk with your doctor. You ask for the PrEP shot. She agrees, types up the prescription, and sends you home feeling like the responsible king you are. Then nothing. No injection. No call. Just a quiet "no" from somewhere inside your insurance company. That is not a hypothetical horror story. According to a poster presented at IDWeek 2026 in Washington, D.C., and reported this week by Gayety, about 4 in 10 patients at a large St. Louis HIV clinic who were prescribed long-acting injectable PrEP never got a single shot. The researchers, led by Dr. Aditi Ramakrishnan at Washington University, looked back at records from February 2022 through July 2026. Of 268 people prescribed the injection, 163 received it and 105 did not, AJMC reported. So who, exactly, said no?
Meet the villain: a form with fax-machine energy
Spoiler: it wasn't the patients. In a closer look at 170 people prescribed the shot, AJMC reported that 70 never started it. Among those 70, 54.3% had no pharmacy benefit that would cover it, and 41.4% were hit with a prior authorization denial. Some people got both. Only a small slice of the no-shows chose to stay on daily pills instead. The rest wanted the shot and were blocked by paperwork. Your body was ready. Your benefits plan was not. The billing details matter more than they should. AJMC reported that 94% of people who got the injection had it covered through a pharmacy benefit, while medical-benefit coverage almost never got a needle in an arm. "We found that medical benefits rarely led to a successful injection in this clinic environment," Ramakrishnan told AJMC. Seven patients even switched clinics just to get the shot covered. And Medicaid? Ramakrishnan told AJMC that Missouri's Medicaid program does not cover long-acting PrEP, even though the state expanded Medicaid. Which brings us to the part that stings.
The twist that should make every insurer blush
The study had a clear gap in who stayed protected. At 12 months, 96% of people who got the shot still had an active PrEP prescription, compared with 72.9% of those who were turned away, AJMC reported. One person in the study acquired HIV. According to AJMC, that person had been taking oral PrEP inconsistently and had been denied coverage for the injection the year before. The researchers are careful here, and so are we: this was one clinic, a look back at records, and a conference poster rather than a published journal article. It cannot prove the shot caused the difference. But the authors' conclusion was blunt. "Policymakers must address this gap to achieve effective LAI PrEP implementation to end the epidemic," they wrote, according to AJMC. This is a big deal because the tools are genuinely good.
NOCTI's take: Your sexual health shouldn't need a permission slip
This is our opinion, and we're saying it with our whole chest: we have a twice-a-year HIV prevention shot, and the thing standing between a man and his protection is a billing category. Science did its homework. The paperwork is still out sick. We love that more men are asking for PrEP without blushing. That's the energy. But wanting care and getting care are two different sports, and right now too many guys are being benched by forms they have never seen. Nobody should feel embarrassed for asking, for switching, or for needing a plan B. Prevention is self-care, period.
How to get your PrEP (and keep your glow) in five moves
Here's the good news. PrEP works. The CDC says PrEP reduces the risk of getting HIV from sex by about 99% when taken as prescribed, and it comes as pills or shots. The FDA approved Yeztugo, a twice-a-year injection, in June 2025, joining Apretude, which is given every two months, according to Drugs.com's report on the approval. So here is your game plan: 1. Ask the billing question up front. When your provider prescribes the shot, ask: "Will this run through my pharmacy benefit or my medical benefit?" That one sentence was the difference-maker in this study. 2. If you get denied, don't ghost. Ask the clinic to resubmit or appeal the prior authorization, and ask whether they have a PrEP navigator or benefits coordinator who handles this every day. 3. Stay covered while you fight. If the shot is stuck, ask about starting or staying on PrEP pills in the meantime, and take them as prescribed. A gap in protection is the real risk here, not the form. 4. Know your emergency backup. If you think you were exposed to HIV and you're not protected, PEP is a short course of medicine that the CDC's 2025 recommendations say should start as soon as possible, ideally within 24 hours and no later than 72 hours after exposure. Call a clinic, urgent care, or ER right away. 5. Keep showing up. Stay on top of your follow-up visits and testing. The people who stayed in care were the ones who stayed protected. Confidence looks good on you. So does a plan.
Before you go, gorgeous
The takeaway: the shot isn't the hard part anymore. The paperwork is, and you're allowed to fight it. Looking for men's health resources and providers who treat you like an adult, with zero judgment? Start at joinnocti.com/discover. This article is for general information and isn't medical advice.
Sources
Gayety, "Insurance Barriers Block Injectable PrEP Access" (Oct 28, 2026): https://gayety.com/injectable-prep-insurance-barriers-st-louis-study AJMC, "Insurance Barriers Tied to Missed Long-Acting PrEP Starts" (Oct 22, 2026): https://www.ajmc.com/view/insurance-barriers-tied-to-missed-long-acting-prep-starts AJMC, "Insurance Barriers Block 4 in 10 From Injectable HIV PrEP" (Oct 23, 2026): https://www.ajmc.com/view/insurance-barriers-block-4-in-10-from-injectable-hiv-prep CDC, "#ShesWell: PrEP for Women" (Oct 16, 2024): https://www.cdc.gov/stophivtogether/sheiswell/index.html Drugs.com, "FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo" (Jun 20, 2025): https://www.drugs.com/news/fda-approves-first-twice-year-hiv-prevention-shot-125459.html CDC, "Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025" (May 8, 2025): https://www.cdc.gov/mmwr/volumes/74/rr/rr7401a1.htm
Find men’s massage near you
Compare local providers privately and contact the professional you choose directly.
Search NOCTI